Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 11 Nov, 2024
In a recent conversation with Ankit Kankar from BioSpectrum Asia, Yvonne Lungershausen, CEO of Avance Clinical, shared i...Read more
Trump’s Trade Tango Returns: Will China’s Biotech Dance Through Another Round of Tariffs or Stumble?
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 09 Nov, 2024
With Donald Trump’s return to the White House, the U.S.-China trade relationship is once again in the spotlight. T...Read more
EVŌQ Nano CEO Shaun Rothwell Discusses Advanced Antimicrobial Solution EVQ-218 and Its Impact on AMR
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 06 Nov, 2024
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...Read more
Pharma and Biotech Layoffs Signal Strategic Shift Towards Efficiency Amid Industry Restructuring
Specials | Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 05 Nov, 2024
The current wave of layoffs across the pharmaceutical and biotech sectors, affecting major companies like Pfizer...Read more
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 14 Oct, 2024
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...Read more
Biopharma Giants Face Industry-Wide Layoffs Amid Economic Pressures
Specials | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 1 Comment | 01 Oct, 2024
The biopharmaceutical and healthcare industries, long seen as cornerstones of innovation, are currently grappling with a...Read more
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 02 Sep, 2024
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...Read more
Biotech's Summer Clean-Up: When Cutting Edge Means Cutting Jobs
Specials | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 31 Jul, 2024
The biotech industry, renowned for its rapid advancements and groundbreaking research, faced a significant wave of layof...Read more
MedTech Giants Drive Innovation and Growth: Key Developments and Achievements
Specials | Analysis | By Sakshi Kamble | sakshi.kamble@biospectrumasia.com | 0 Comment | 15 Jul, 2024
Over the past six months, the leading MedTech companies have made remarkable progress in product innovation, strategic p...Read more
Pierre-Alain Ruffieux Joins Cytiva as COO, Sets Sights on Asia Pacific Growth
Specials | Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 2 Comment | 04 Jul, 2024
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...Read more
Life Sciences Industry Faces Setbacks: The Impact of Failed Clinical Trials in 2024
Specials | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 1 Comment | 28 Jun, 2024
The Life Sciences Industry: Pitfalls and the Impact of Failed Clinical Trials in 2024 The life sciences industry is at ...Read more
Specials | News | 0 Comment | 24 Jun, 2024
Ravindra Boratkar, Publisher & Managing Editor, BioSpectrum (India and Asia), NUFFOODS Spectrum (India and A...Read more
The Evolution of the Pharmaceutical Landscape: A Two-Decade Journey of Mergers and Acquisitions
Specials | News | By Sakshi Kamble | sakshi.kamble@biospectrumasia.com | 0 Comment | 24 Jun, 2024
The following report provides detailed analysis of Mergers and Acquisitions of BioPharma and Pharmaceuticals companies u...Read more
Navigating Turbulent Waters: How Workforce Reductions Reflect Broader Industry Trends
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 04 Jun, 2024
A Shifting Landscape: The Bio Industry's May 2024 Layoffs May 2024 witnessed a wave of layoffs across the bio industry,...Read more
Turbulence in Pharma: A Wave of Layoffs Sweeps Through the Industry
Specials | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 08 May, 2024
The pharmaceutical and biotechnology industries are undergoing a significant upheaval, with a series of layoffs announce...Read more
Biotech and Pharma's March Shake-Up: Layoffs Signal Industry Evolution
Specials | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 01 Apr, 2024
March 2024 has been marked by a series of layoffs in the biotech and pharmaceutical sector, raising concerns and drawing...Read more
Specials | Analysis | By Ayesha Siddiqui | 0 Comment | 01 Mar, 2024
GlaxoSmithKline's (GSK) appointment of Emma Walmsley as CEO in 2016 made headlines for more than one reason. Notably, sh...Read more
February's Bold Pivot: Layoffs Ignite Strategic Renewal in Biotech & BioPharma Industry
Specials | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 28 Feb, 2024
In February, the Biotech and BioPharma industries faced a wave of strategic layoffs, signaling a significant shift towar...Read more